Throat Carcinoma — Trials

Throat Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,035 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 369
Recruiting: 201
Ph III recruiting: 58
Growth YoY: +7.8%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (87)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00031681	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	completed	Phase 1	41	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT00049166	Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer	completed	Phase 1	48	National Cancer Institute (NCI)NIH	1